p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

被引：0
|
作者：
Jiao Meng
Wei Qian
Zhenkun Yang
Lingli Gong
Daxing Xu
Hongbo Huang
Xinyi Jiang
Zhening Pu
Ying Yin
Jian Zou
机构：
[1] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Laboratory Medicine, Wuxi People’s Hospital, Wuxi Medical Center
[2] Nanjing Medical University,Center of Clinical Research, Wuxi People’s Hospital, Wuxi Medical Center
[3] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine
[4] Nanjing Medical University, Department of Clinical Laborator
[5] Jiangsu Institute of Nuclear Medicine,undefined
[6] Kunshan Hospital of Traditional Chinese Medicine,undefined
[7] Kunshan,undefined
来源：
BMC Cancer | / 24卷
关键词：
E2F7; p53; Chemoresistance; Temozolomide; Glioblastoma multiforme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Deubiquitinating enzyme 4 facilitates chemoresistance in glioblastoma by inhibiting P53 activity
    Qin, Na
    Han, Fengli
    Li, Li
    Ge, Yingwei
    Lin, Wei
    Wang, Jiang
    Wu, Lin
    Zhao, Gang
    Deng, Yanchun
    Zhang, Jian
    ONCOLOGY LETTERS, 2019, 17 (01) : 958 - 964
  • [32] The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells
    Maria Grazia di Iasio
    Giorgio Zauli
    Investigational New Drugs, 2013, 31 : 458 - 460
  • [33] Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
    England, Bryant
    Huang, Tiangui
    Karsy, Michael
    TUMOR BIOLOGY, 2013, 34 (04) : 2063 - 2074
  • [34] Neuropilin-1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis
    Huang, Ping
    Zhang, Lixia
    Wang, Hongwei
    Dou, Changwu
    Ju, Haitao
    Yue, Peng
    Ren, Jiaxing
    NEUROPATHOLOGY, 2024, 44 (04) : 319 - 330
  • [35] E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis
    Rogoff, HA
    Pickering, MT
    Debatis, ME
    Jones, S
    Kowalik, TF
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) : 5308 - 5318
  • [36] The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
    Giulia Fontemaggi
    Stefania Dell'Orso
    Daniela Trisciuoglio
    Tal Shay
    Elisa Melucci
    Francesco Fazi
    Irene Terrenato
    Marcella Mottolese
    Paola Muti
    Eytan Domany
    Donatella Del Bufalo
    Sabrina Strano
    Giovanni Blandino
    Nature Structural & Molecular Biology, 2009, 16 : 1086 - 1093
  • [37] The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
    Fontemaggi, Giulia
    Dell'Orso, Stefania
    Trisciuoglio, Daniela
    Shay, Tal
    Melucci, Elisa
    Fazi, Francesco
    Terrenato, Irene
    Mottolese, Marcella
    Muti, Paola
    Domany, Eytan
    Del Bufalo, Donatella
    Strano, Sabrina
    Blandino, Giovanni
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (10) : 1086 - U111
  • [38] E2F7 and E2F8 keep the E2F family in balance
    Moon, Nam-Sung
    Dyson, Nicholas
    DEVELOPMENTAL CELL, 2008, 14 (01) : 1 - 3
  • [39] Novel 9-Methylanthracene Derivatives as p53 Activators for the Treatment of Glioblastoma Multiforme
    Feng, Yuxin
    Wang, Yingjie
    Li, Xiaoxue
    Sun, Ziqiang
    Qiang, Sihan
    Wang, Hongbo
    Liu, Yi
    MOLECULES, 2024, 29 (10):
  • [40] JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer
    Pan, Chun-Wu
    Qi, Jun
    Wang, Liguo
    Qian, Chenchen
    Zhao, Yu
    Liu, Hailong
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 125 - 125
12345